ALEXANDER, Matthew D.,ARTMAN III, Gerald D.,BRAY, Gordon L.,CARMICHAEL, James,CARRANCIO, Soraya,CATHERS, Brian E.,CORREA, Matthew D.,HANSEN, Joshua,HAVENS, Courtney G.,KERCHER, Timothy S.,LOPEZ-GIRONA
申请号：
AU2018301335
公开号：
AU2018301335A1
申请日:
2018.07.09
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
Provided herein is 4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile, or an enantiomer, a mixture of enantiomers, a tautomer, or a pharmaceutically acceptable salt thereof, and methods for treating, preventing or managing multiple myeloma using such compounds. Also provided are pharmaceutical compositions comprising the compounds, and methods of use of the compositions.
